(NYSE: PACS) Pacs Group's forecast annual revenue growth rate of 8.49% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.84%.
Pacs Group's revenue in 2026 is $5,551,038,000.On average, 8 Wall Street analysts forecast PACS's revenue for 2026 to be $942,571,898,236, with the lowest PACS revenue forecast at $900,296,289,832, and the highest PACS revenue forecast at $983,422,486,132. On average, 8 Wall Street analysts forecast PACS's revenue for 2027 to be $1,032,981,532,688, with the lowest PACS revenue forecast at $960,147,151,168, and the highest PACS revenue forecast at $1,117,057,742,660.
In 2028, PACS is forecast to generate $1,128,457,906,724 in revenue, with the lowest revenue forecast at $1,024,748,080,864 and the highest revenue forecast at $1,215,225,822,100.